SERVICES

CellAppliedResearch offers a range of services to support companies or institutions with their R&D programs related to biotechnology. The consultant is an expert in cell therapy, from initial discovery to commercial scale manufacturing. Next to experimental design, implementation of the latest technology, creating a large network of experts, the consultant has also built experience in managing international teams.

KNOWHOW

Jef Pinxteren is trained in biochemistry and cell biology and has experience with protein expression and purification, cell signalling, cell culture, stem cells, immunology, media development, bioreactor expansion, comparability exercises and proteomics.

ACTIVITIES

I am very active in the cell therapy community, been a member of the International Society for Cell and Gene Therapy (ISCT) from the start. I have also contributed to many other cell therapy symposia and activities. More than 25 years experience as reviewer for more than 10 international journals in life sciences.
I lived more than 6 years abroad and I am willing to travel and to take on international assignments

From R&D to Manufacturing

Request more information

Short biography

Jef Pinxteren obtained his PhD in Biochemistry at the University of Antwerp in 1994. He then moved to University College London supported by a long-term EMBO fellowship. He studied the role of G-proteins in secretion from granulocytes, with further funding from the Medical Research Council and the Wellcome Trust he continued the research project. With UCL Bogue fellowships, he started US collaborations with UAB in Alabama, and UNC in North Carolina. Here he built experience with mouse ES cells, knock-out models and cell differentiation assays. In 2000 he returned to Belgium and started on cord blood derived stem cells, then mesenchymal stem cells and collaborated with the Stem Cell Institute in Minneapolis. In 2004 he moved to the proteomics group of the Flemish Institute of Biotechnology. In 2006, he started for Athersys in Cleveland, as Head of R&D and set up the daughter company ReGenesys in Belgium. Late 2016 he started to work for Promethera Biosciences, until the end of 2019 as global VP Operations. In 2020 he joined Catalent Gene and Cell Therapy, functioning as Senior Director Process and Analytical Development.